Skip to main content

TMZ 180 Pill - maroon white capsule/oblong, 9mm

Pill with imprint TMZ 180 is Maroon / White, Capsule/Oblong and has been identified as Temozolomide 180 mg. It is supplied by Accord Healthcare Inc.

Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TMZ 180

Temozolomide 180 mg TMZ 180
Temozolomide 180 mg TMZ 180

Temozolomide

Imprint
TMZ 180
Strength
180 mg
Color
Maroon / White
Size
9.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Accord Healthcare Inc.
National Drug Code (NDC)
16729-0130
Inactive Ingredients
lactose anhydrous, silicon dioxide, sodium starch glycolate type A potato, tartaric acid, stearic acid, ferric oxide red, gelatin, titanium dioxide, ferric oxide yellow, shellac, potassium hydroxide, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.